The role of retinal regulation of sleep in health and disease

Sleep Medicine Reviews

Volumn 15, Issue 2, 2011, Pages 107-113

  Schmoll, Conrad ^a   Lascaratos, Gerassimos ^a   Dhillon, Bal ^a   Skene, Debra ^b   Riha, Renata L ^c  

^a Princess Alexandra Eye Pavilion ^*  (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Blind; Circadian rhythm; IpRGCs; Retinal regulation

Indexed keywords

CIRCADIAN RHYTHM SLEEP DISORDER; EYE DISEASE; HUMAN; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHOTOSENSITIVITY; PHOTOTRANSDUCTION; PHYSIOLOGICAL PROCESS; RETINA GANGLION CELL; REVIEW; SLEEP DISORDER; SLEEP PATTERN;

HUMANS; PHOTOPERIOD; PHOTORECEPTOR CELLS, VERTEBRATE; RETINA; RETINAL GANGLION CELLS; ROD OPSINS; SLEEP DISORDERS, CIRCADIAN RHYTHM; VISION, OCULAR;

EID: 79951771265     PISSN: 10870792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smrv.2010.06.001     Document Type: Review

References (99)

1. Peirson S.N., Halford S., Foster R.G. The evolution of irradiance detection: melanopsin and the non-visual opsins. Philos Trans R Soc Lond B Biol Sci 2009 Oct 12, 364(1531):2849-2865.
2. Berson D.M. Strange vision: ganglion cells as circadian photoreceptors. Trends Neurosci 2003, 26:314-320.
3. Turner P.L., Mainster M.A. Circadian photoreception: ageing and the eye's important role in systemic health. Br J Ophthalmol 2008, 92:1439-1444.
4. Turner P.L., Van Someren E.J., Mainster M.A. The role of environmental light in sleep and health: effects of ocular ageing and cataract surgery. Sleep Med Rev 2010, [Epub ahead Print, Jan 5, 2010, PubMed ID 20056462].
5. Borbely A.A. A two process model of sleep regulation. Hum Neurobiol 1982, 1:195-204.
6. Aschoff J., Fatranská M., Giedke H., Doerr P., Stamm D., Wisser H. Human circadian rhythms in continuous darkness: entrainment by social cues. Science 1971 Jan 15, 171(967):213-215.
7. Czeisler C.A. The effect of light on the human circadian pacemaker. Ciba Found Symp 1995, 183:254-290. Discussion 90-302.
8. Sack R.L., Lewy A.J., Blood M.L., Keith L.D., Nakagawa H. Circadian rhythm abnormalities in totally blind people: incidence and clinical significance. J Clin Endocrinol Metab 1992, 75:127-134.
9. Lockley S.W., Skene D.J., Arendt J., Tabandeh H., Bird A.C., Defrance R. Relationship between melatonin rhythms and visual loss in the blind. J Clin Endocrinol Metab 1997, 82:3763-3770.
10. Revell V.L., Skene D.J. Impact of age on human non-visual responses to light. Sleep Biol Rhythms 2010, 8:84-94.
11. Mistlberger R., Skene D.J. Nonphotic entrainment in humans?. J Biol Rhythms 2005, 20:339-352.
12. Klein D.C., Moore R.Y., Reppert S.M. Suprachiasmatic nucleus: the Mind's clock 1991, Oxford University Press.
13. Rajaratnam S.M., Arendt J. Health in a 24-h society. Lancet 2001, 358:999-1005.
14. Dunlap J.C., Loros J.J., DeCoursey P.J. Chronobiology: biological timekeeping 2004, Sinauer, Sunderland, Massachusetts.
15. Johnson R.F., Moore R.Y., Morin L.P. Loss of entrainment and anatomical plasticity after lesions of the hamster retinohypothalamic tract. Brain Res 1988, 460:297-313.
16. Moore R.Y., Lenn N.J. A retinohypothalamic projection in the rat. J Comp Neurol 1972, 146:1-14.
17. Arendt J. Melatonin and the mammalian pineal gland 1995, Chapman and Hall, London.
18. Rusak B., Zucker I. Neural regulation of circadian rhythms. Physiol Rev 1979, 59:449-526.
19. Vaughan G.M., McDonald S.D., Jordan R.M., Allen J.P., Bohmfalk G.L., Abao-Samra M., et al. Melatonin concentration in human blood and cerebrospinal fluid: relationship to stress. J Clin Endocrinol Metab 1978, 47:220-223.
20. Arendt J., Bojkowski C., Franey C., Wright J., Marks V. Immunoassay of 6-hydroxymelatonin sulfate in human plasma and urine: abolition of the urinary 24-h rhythm with atenolol. J Clin Endocrinol Metab 1985, 60:1166-1173.
21. Markey S.P., Higa S., Shih M., Danforth D.N., Tamarkin L. The correlation between human plasma melatonin levels and urinary 6-hydroxymelatonin excretion. Clin Chim Acta 1985, 150:221-225.
22. Bojkowski C.J., Aldhous M.E., English J., Franey C., Poulton A.L., Skene D.J., et al. Suppression of nocturnal plasma melatonin and 6-sulphatoxymelatonin by bright and dim light in man. Horm Metab Res 1987, 19:437-440.
23. Bojkowski C.J., Arendt J., Shih M.C., Markey S.P. Melatonin secretion in humans assessed by measuring its metabolite, 6-sulphatoxymelatonin. Clin Chem 1987, 33:1343-1348.
24. Shand J., Foster R.G. The extraretinal photoreceptors of non-mammalian vertebrates. Adaptive mechanisms in the ecology of vision 1999, 197-222. Kluwer Academic. S.N. Archer (Ed.).
25. Nelson R.J., Zucker I. Absence of extra-ocular photoreception in diurnal and nocturnal rodents exposed to direct sunlight. Comp Biochem Physiol A 1981, 69:145-148.
26. Nelson D.E., Takahashi J.S. Comparison of visual sensitivity for suppression of pineal melatonin and circadian phase-shifting in the golden hamster. Brain Res 1991, 554:272-277.
27. Gatterman R., Johnston R.E., Yigit N., Fritzsche P., Larimer S., Ozkurt S., et al. Golden hamsters are nocturnal in captivity but diurnal in nature. Biol Lett 2008, 4(3):253-255.
28. Bullough J.D., Rea M.S., Figueiro M.G. Of mice and women: light as a circadian stimulus in breast cancer research. Cancer Causes Control 2006, 17(4):375-383.
29. Thapan K., Arendt J., Skene D.J. An action spectrum for melatonin suppression: evidence for a novel non-rod, non-cone photoreceptor system in humans. J Physiol 2001, 535:261-267.
30. Brainard G.C., Hanifin J.P., Greeson J.M., Byrne B., Glickman G., Gerner E., et al. Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. J Neurosci 2001, 21:6405-6412.
31. Foster R.G., Provencio I., Hudson D., Fiske S., De Grip W., Menaker M. Circadian photoreception in the retinally degenerate mouse (rd/rd). J Comp Physiol A 1991, 169:39-50.
32. David-Gray Z.K., Janssen J.W., DeGrip W.J., Nevo E., Foster R.G. Light detection in a 'blind' mammal. Nat Neurosci 1998, 1:655-656.
33. Czeisler C.A., Shanahan T.L., Klerman E.B., Martens H., Brotman D.J., Emens J.S., et al. Suppression of melatonin secretion in some blind patients by exposure to bright light. N Engl J Med 1995, 332(6):6-11.
34. Freedman M.S., Lucas R.J., Soni B., von Schantz M., Muñoz M., David-Gray Z., et al. Regulation of mammalian circadian behavior by non-rod, non-cone, ocular photoreceptors. Science 1999, 284:502-504.
35. Lucas R.J., Freedman M.S., Muñoz M., Garcia-Fernández J.M., Foster R.G. Regulation of the mammalian pineal by non-rod, non-cone, ocular photoreceptors. Science 1999, 284:505-507.
36. Lucas R.J., Douglas R.H., Foster R.G. Characterization of an ocular photopigment capable of driving papillary constriction in mice. Nat Neurosci 2001, 4:621-626.
37. Provencio I., Rodriguez I.R., Jiang G., Hayes W.P., Moreira E.F., Rollag M.D. A novel human opsin in the inner retina. J Neurosci 2000, 20:600-605.
38. Hannibal J., Hindersson P., Knudsen S.M., Georg B., Fahrenkrug J. The photopigment melanopsin is exclusively present in pituitary adenylate cyclase-activating polypeptide-containing retinal ganglion cells of the retinohypothalamic tract. J Neurosci 2002, 22:RC191.
39. Hattar S., Liao H.W., Takao M., Berson D.M., Yau K.W. Melanopsin-containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity. Science 2002, 295:1065-1070.
40. Berson D.M. Phototransduction by retinal ganglion cells that set the circadian clock. Science 2002, 295:1070-1073.
41. Panda S., Sato T.K., Castrucci A.M., Rollag M.D., DeGrip W.J., Hogenesch J.B., et al. Melanopsin (Opn4) requirement for normal light-induced circadian phase shifting. Science 2002, 298:2213-2216.
42. Ruby N.F., Brennan T.J., Xie X., Cao V., Franken P., Heller H.C., et al. Role of melanopsin in circadian responses to light. Science 2002, 298:2211-2213.
43. Lucas R.J., Hattar S., Takao M., Berson D.M., Foster R.G., Yau K.W. Diminished pupillary light reflex at high irradiances in melanopsin-knockout mice. Science 2003, 299:245-247.
44. Dacey D.M., Liao H.W., Peterson B.B., Robinson F.R., Smith V.C., Pokorny J., et al. Melanopsin-expressing ganglion cells in primate retina signal colour and irradiance and project to the LGN. Nature 2005, 433:749-754.
45. Güler A.D., Ecker J.L., Lall G.S., Haq S., Altimus C.M., Liao H.W., et al. Melanopsin cells are the principal conduits for rod-cone input to non-image-forming vision. Nature 2008 May 1, 453(7191):102-105.
46. Melyan Z., Tartellan E.E., Bellingham J., Lucas R.J., Hankins M.W. Addition of melanopsin renders mammalian cells photoresponsive. Nature 2005, 433:741-745.
47. Mure L.S., Rieux C., Hattar S., Cooper H.M. Melanopsin-dependent nonvisual responses:evidence for photopigment bistability in vivo. J Biol Rhythms 2007, 22:411-424.
48. Mure L.S., Cornut P.L., Rieux C., Drouyer E., Denis P., Gronfier C., et al. Melanopsin bistability: a fly's eye technology in the human retina. PLoS One 2009, 4:e5991.
49. Hankins M.W., Peirson S.M., Foster R.G. Melanopsin: an exciting photopigment. Trends Neurosci 2008 Jan, 31(1):27-36.
50. Gooley J.J., Lu J., Fischer D., Saper C.B. A broad role for melanopsin in nonvisual photoreception. J Neurosci 2003, 23:7093-7106.
51. Foster R.G., Hankins M.W. Non-rod, non-cone photoreception in the vertebrates. Prog Retin Eye Res 2002, 21:507-527.
52. Hastings M.H. A clockwork web: circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci 2003, 4:649-661.
53. Cajochen C., Jud C., Munch M., Kobialka S., Wirz-Justice A., Albrecht U. Evening exposure to blue light stimulates the expression of the clock gene PER2 in humans. Eur J Neurosci 2006, 23:1082-1086.
54. Vandewalle G., Maquet P., Dijk D.J. Light as a modulator of cognitive brain function. Trends Cogn Sci 2009 Oct, 13(10):429-438.
55. Vandewalle G., Schmidt C., Albouy G., Sterpenich V., Darsaud A., Rauchs G., et al. Brain responses to violet, blue, and green monochromatic light exposures in humans: prominent role of blue light and the brainstem. PLoS One 2007 Nov 28, 2(11):e1247.
56. Vandewalle G., Gais S., Schabus M., Balteau E., Carrier J., Darsaud A., et al. Wavelength-dependent modulation of brain responses to a working memory task by daytime light exposure. Cereb Cortex 2007 Dec, 17(12):2788-2795.
57. Vandewalle G., Balteau E., Phillips C., Degueldre C., Moreau V., Sterpenich V., et al. Daytime light exposure dynamically enhances brain responses. Curr Biol 2006 Aug 22, 16(16):1616-1621.
58. Viola A.U., James L.M., Schlangen L.J., Dijk D.J. Blue-enriched white light in the workplace improves self-reported alertness, performance and sleep quality. Scand J Work Environ Health 2008 Aug, 34(4):297-306.
59. Revell V.L., Arendt J., Terman M., Skene D.J. Short-wavelength sensitivity of the human circadian system to phase-advancing light. J Biol Rhythms 2005, 20:270-272.
60. Revell V.L., Arendt J., Fogg L.F., Skene D.J. Alerting effects of light are sensitive to very short wavelengths. Neurosci Lett 2006, 399:96-100.
61. Lockley S.W., Brainard G.C., Czeisler C.A. High sensitivity of the human circadian melatonin rhythm to resetting by short wavelength light. J Clin Endocrinol Metab 2003, 88:4502-4505.
62. Lockley S.W., Evans E.E., Scheer F.A., Brainard G.C., Czeisler C.A., Aeschbach D. Short-wavelength sensitivity for the direct effects of light on alertness, vigilance, and the waking electroencephalogram in humans. Sleep 2006, 29:161-168.
63. Cajochen C., Munch M., Kobialka S., Krauchi K., Steiner R., Oelhafen P., et al. High sensitivity of human melatonin, alertness, thermoregulation, and heart rate to short wavelength light. J Clin Endocrinol Metab 2005, 90:1311-1316.
64. Sletten T.L., Revell V.L., Middleton B., Lederle K.A., Skene D.J. Age-related changes in acute and phase-advancing responses to monochromatic light. J Biol Rhythms 2009, 24:73-84.
65. Sack R.L., Auckley D., Auger R.R., Carskadon M.A., Wright K.P., Vitiello M.V., et al. American Academy of Sleep Medicine. Circadian rhythm sleep disorders: part I, basic principles, shift work and jet lag disorders. An American academy of sleep medicine review. Sleep 2007 Nov 1, 30(11):1460-1483.
66. Sack R.L., Auckley D., Auger R.R., Carskadon M.A., Wright K.P., Vitiello M.V., Zhdanova I.V. American academy of sleep medicine. Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm. An American academy of sleep medicine review. Sleep 2007 Nov 1, 30(11):1484-1501.
67. Dijk D.J., Archer S.N. PERIOD3, circadian phenotypes, and sleep homeostasis. Sleep Med Rev 2010 Jun, 14(3):151-160.
68. Dijk D.J., Archer S.N. Light, sleep, and circadian rhythms: together again. PLoS Biol 2009 Jun 16, 7(6):e1000145.
69. Viola A.U., Archer S.N., James L.M., Groeger J.A., Lo J.C., Skene D.J., et al. PER3 polymorphism predicts sleep structure and waking performance. Curr Biol 2007 Apr 3, 17(7):613-618.
70. Wulff K., Porcheret K., Cussans E., Foster R.G. Sleep and circadian rhythm disturbances: multiple genes and multiple phenotypes. Curr Opin Genet Dev 2009 Jun, 19(3):237-246.
71. Skene D.J., Arendt J. Circadian rhythm sleep disorders in the blind and their treatment with melatonin. Sleep Med 2007 Sep, 8(6):651-655.
72. Tabandeh H., Lockley S.W., Buttery R., Skene D.J., Defrance R., Arendt J., et al. Disturbance of sleep in blindness. Am J Ophthalmol 1998 Nov, 126(5):707-712.
73. Miles L.E.M., Wilson M.A. High incidence of cyclic sleep/wake disorders in the blind. Sleep Res 1977, 6:192.
74. Sasaki H., Nakata H., Murakami S., Uesugi R., Harada S., Teranishi M. Circadian sleep-waking rhythm disturbance in blind adolescence. Jpn J Psychiatry Neurol 1992 Mar, 46(1):209.
75. Moseley M.J., Fouladi M., Jones H.S., Tobin M.J. Sleep disturbance and blindness. Lancet 1996 Nov 30, 348(9040):1514-1515.
76. Leger D., Guilleminault C., Defrance R., Domont A., Paillard M. Blindness and sleep patterns. Lancet 1996 Sep 21, 348(9030):830-831.
77. Klein T., Martens H., Dijk D.J., Kronauer R.E., Seely E.W., Czeisler C.A. Circadian sleep regulation in the absence of light perception: chronic non-24-h circadian rhythm sleep disorder in a blind man with a regular 24-h sleep-wake schedule. Sleep 1993 Jun, 16(4):333-343.
78. Lockley S.W., Skene D.J., Butler L., Arendt J. Sleep and activity rhythms are related to circadian phase in the blind. Sleep 1999, 22:616-623.
79. Lockley S.W., Dijk D.J., Kosti O., Skene D.J., Arendt J. Alertness, mood and performance rhythm disturbances associated with circadian sleep disorders in the blind. J Sleep Res 2008, 17:207-216.
80. Pérez-Rico C., de la Villa P., Blanco R., Germain F., Paz-Moreno J., Arribas-Gómez I. Arch Soc Esp Oftalmol 2009 May, 84(5):251-257.
81. Jean-Louis G., Zizi F., Lazzaro D.R., Wolintz A.H. Circadian rhythm dysfunction in glaucoma: a hypothesis. J Circadian Rhythms 2008 Jan 10, 6:1.
82. Hofstra W.A., de Weerd A.W. How to assess circadian rhythm in humans: a review of literature. Epilepsy Behav 2008 Oct, 13(3):438-444.
83. Morgenthaler T.I., Lee-Chiong T., Alessi C., Friedman L., Aurora R.N., Boehlecke B., et al. Standards of practice committee of the American academy of sleep medicine. Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of sleep medicine report. Sleep 2007 Nov 1, 30(11):1445-1459.
84. Skene D.J., Lockley S.W., James K., Arendt J. Correlation between urinary cortisol and 6-sulphatoxymelatonin rhythms in field studies of blind subjects. Clin Endocrinol 1999, 50:715-719.
85. Arnulf I., Leu S., Oudiette D. Abnormal sleep and sleepiness in Parkinson's disease. Curr Opin Neurol 2008 Aug, 21(4):472-477.
86. Friedman J.H., Millman R.P. Sleep disturbances and Parkinson's disease. CNS Spectr 2008 Mar, 13(3 Suppl. 4):12-17.
87. Mehta S.H., Morgan J.C., Sethi K.D. Sleep disorders associated with Parkinson's disease: role of dopamine, epidemiology, and clinical scales of assessment. CNS Spectr 2008 Mar, 13(3 Suppl. 4):6-11.
88. Archibald N.K., Clarke M.P., Mosimann U.P., Burn D.J. The retina in Parkinson's disease. Brain 2009 May, 132(Pt 5):1128-1145.
89. Willis G.L. Parkinson's disease as a neuroendocrine disorder of circadian function: dopamine-melatonin imbalance and the visual system in the genesis and progression of the degenerative process. Rev Neurosci 2008, 19(4-5):245-316.
90. Mahowald M.W., Schenk C.H. The REM sleep behavior disorder odyssey. Sleep Med Rev 2009 Dec, 13(6):381-384.
91. Hajee M.E., March W.F., Lazzaro D.R., Wolintz A.H., Shrier E.M., Glazman S., et al. Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol 2009 Jun, 127(6):737-741.
92. Herljevic M., Middleton B., Thapan K., Skene D.J. Light-induced melatonin suppression: age-related reduction in response to short-wavelength light. Exp Gerontol 2005, 40:237-242.
93. Mainster M.A. Violet and blue light blocking intraocular lenses: photoprotection versus photoreception. Br J Ophthalmol 2006, 90:784-792.
94. Cuthbertson F.M., Peirson S.N., Wulff K., Foster R.G., Downes S.M., et al. Blue light-filtering intraocular lenses: review of potential benefits and side effects. J Cataract Refract Surg 2009, 35:1281-1297.
95. Asplund R., Edjervik Lindblad B. The development of sleep in persons undergoing cataract surgery. Arch Gerontol Geriatr 2002 Sep-Oct, 35(2):179-187.
96. Asplund R., Edjervik Lindblad B. Sleep and sleepiness 1 and 9 months after cataract surgery. Arch Gerontol Geriatr 2004 Jan-Feb, 38(1):69-75.
97. Riemersma R.F., Swaab D.F., Twisk J., Hol E.M., Hoogendijk W.J., Van Someren E.J. Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomised controlled trial. JAMA 2008, 299:2642-2655.
98. Mainster M.A., Turner P.L. Blue-blocking IOLs decrease photoreception without providing significant photoprotection. Surv Ophthalmol 2010, [Epup ahead of print, Oct 31, 2009, Pubmed ID 19883931].
99. McCarty C.A., Mukesh B.N., Fu C.L.J., Mitchell P., Wang J.J., Taylor H.R. Risk factors for age-related maculopathy: the visual impairment Project. Arch Ophthalmol 2001, 119:1455-1462.